Explore groundbreaking studies, clinical trial updates, and emerging technologies shaping the future of cancer treatment.
Discover how neratinib, a second-generation targeted therapy, is proving effective against HER2-mutant breast cancers, offering new hope where traditional treatments sometimes fail.